Grove Bank & Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History

Grove Bank & Trust’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$587	Sell	2 -9	-82%	-$2.55K	﹤0.01%	854
2026 Q1	$3.07K	Sell	11 -17	-61%	-$4.9K	﹤0.01%	757
2025 Q4	$8.48K	Buy	+28	New	+$8.74K	﹤0.01%	665
2025 Q2	–	Sell	-26	Closed	-$6.33K	–	858
2025 Q1	$6.33K	Buy	26 +17	+189%	+$5.11K	﹤0.01%	640
2024 Q4	$2.96K	Hold	9	–	–	﹤0.01%	658
2024 Q3	$3.01K	Buy	+9	New	+$2.86K	﹤0.01%	617

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Grove Bank & Trust's BIO Position: Q2 2026 in Review

Grove Bank & Trust reduced its Bio-Rad Laboratories Class A (BIO) stake by 82% in Q2 2026, selling an estimated $2.55K and leaving 2 shares worth $587. The position accounts for ﹤0.01% of the portfolio, ranked #854.

Grove Bank & Trust first reported a position in BIO in Q3 2024 and has held it in 6 quarters since. The position peaked at $8.48K in Q4 2025. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

Grove Bank & Trust held 2 shares of Bio-Rad Laboratories Class A worth $587 as of Q2 2026.
Grove Bank & Trust sold 9 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $2.55K.
Bio-Rad Laboratories Class A made up ﹤0.01% of Grove Bank & Trust's portfolio in Q2 2026, its #854 holding.
Grove Bank & Trust first reported a position in Bio-Rad Laboratories Class A in Q3 2024 and has held it in 6 quarters since.
Grove Bank & Trust's Bio-Rad Laboratories Class A position peaked at $8.48K in Q4 2025.
399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.